Newer versions of GLP-1 drugs, such as tirzepatide (sold as Zepbound and Mounjaro by Eli Lilly) and Novo Nordisk's upcoming drug CagriSema target more than one type of gut hormone receptor, while retatrutide hits three
Applications include investigating diabetic wound healing, surgical recovery enhancement, and chronic wound management through comprehensive tissue remodeling mechanisms
Side Effects MIC+B12 injections combine a blend of lipotropic agents (Methionine, Inositol, and Choline) with Vitamin B12
How to Report Side Effects Healthcare professionals, patients and caregivers are encouraged to report any suspected adverse reactions to semaglutide, including NAION, via the MHRA Yellow Card scheme: Online at MHRA Yellow Card Reporting, if you are in the United Kingdom Online at FDA MedWatch if you are in the United States Via the Yellow Card app, available on the Apple App Store and Google Play Store Via the NowPatient app When reporting, provide as much information as possible, including medical history, any other medications being taken, when symptoms started and treatment dates